Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasma.
作者信息
Liumbruno Giancarlo Maria, Sodini Maria Laura, Grazzini Giuliano
机构信息
Servizio di Immunoematologia e Medicina Trasfusionale, A USLN, Livorno, Italy.
出版信息
Blood Transfus. 2008 Jan;6(1):25-36. doi: 10.2450/2008.0027-07.
Abstract
摘要
相似文献
1
Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasma.
Blood Transfus. 2008 Jan;6(1):25-36. doi: 10.2450/2008.0027-07.
2
A pathogen reduction clinical trial in retrospect.
Blood Transfus. 2017 Jul;15(4):329-332. doi: 10.2450/2017.0340-16. Epub 2017 Apr 10.
3
Appropriate and inappropriate use of fresh frozen plasma.
J Pak Med Assoc. 2006 Aug;56(8):356-9.
4
Outcomes Related to the Use of Frozen Plasma or Pooled Solvent/Detergent-Treated Plasma in Critically Ill Children.
Pediatr Crit Care Med. 2017 May;18(5):e215-e223. doi: 10.1097/PCC.0000000000001149.
5
Guidelines for the use of fresh frozen plasma.
Acta Clin Belg. 2008 Nov-Dec;63(6):381-90. doi: 10.1179/acb.2008.079.
6
Transfusion audit of fresh-frozen plasma in southern Taiwan.
Vox Sang. 2006 Oct;91(3):270-4. doi: 10.1111/j.1423-0410.2006.00819.x.
7
Increasing compliance with institutional guidelines for fresh-frozen plasma transfusions.
Transfusion. 2007 Nov;47(11):2169-70; author reply 2170. doi: 10.1111/j.1537-2995.2007.01496.x.
8
9
[Guidelines for safer and more appropriate use of blood transfusion systems in Japan].
Nihon Geka Gakkai Zasshi. 2005 Jan;106(1):7-12.
10
[Blood components and good practices in transfusion].
Presse Med. 2015 Feb;44(2):165-77. doi: 10.1016/j.lpm.2014.06.032. Epub 2014 Dec 24.
引用本文的文献
1
Rare congenital bleeding disorders.
Ann Transl Med. 2018 Sep;6(17):331. doi: 10.21037/atm.2018.08.34.
2
Is solvent/detergent plasma better than standard fresh-frozen plasma? A systematic review and an expert consensus document.
Blood Transfus. 2016 Jul;14(4):277-286. doi: 10.2450/2016.0168-15. Epub 2016 Feb 17.
3
Hepatitis E: an old infection with new implications.
Blood Transfus. 2015 Jan;13(1):6-17. doi: 10.2450/2014.0063-14. Epub 2014 Sep 12.
4
Solvent/detergent plasma: pharmaceutical characteristics and clinical experience.
J Thromb Thrombolysis. 2015 Jan;39(1):118-28. doi: 10.1007/s11239-014-1086-1.
5
Posttraumatic massive bleeding: a challenging multidisciplinary task.
Intern Emerg Med. 2010 Dec;5(6):521-31. doi: 10.1007/s11739-010-0396-3. Epub 2010 May 20.
6
Plasma, guidelines, and evidence-based medicine.
Blood Transfus. 2008 Jan;6(1):3-5. doi: 10.2450/2008.0052-07.
本文引用的文献
1
Recommendations for transfusion therapy in neonatology.
Blood Transfus. 2015 Jul;13(3):484-97. doi: 10.2450/2015.0113-15.
2
Transfusion-related acute lung injury and leucocyte-reacting antibodies.
Vox Sang. 2007 Jul;93(1):70-7. doi: 10.1111/j.1423-0410.2007.00920.x.
3
Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross.
Transfusion. 2007 Apr;47(4):599-607. doi: 10.1111/j.1537-2995.2007.01102.x.
4
Donor risk factors for white blood cell antibodies associated with transfusion-associated acute lung injury: REDS-II leukocyte antibody prevalence study (LAPS).
Transfusion. 2007 Apr;47(4):563-4. doi: 10.1111/j.1537-2995.2007.01184.x.
5
Measures to prevent TRALI.
Vox Sang. 2007 Apr;92(3):258-77. doi: 10.1111/j.1423-0410.2006.00870.x.
6
Normal levels of ADAMTS13 and factor H are present in the pharmaceutically licensed plasma for transfusion (Octaplas) and in the universally applicable plasma (Uniplas) in development.
Vox Sang. 2007 Apr;92(3):206-12. doi: 10.1111/j.1423-0410.2006.00884.x.
7
Thrombotic microangiopathies: an update.
Hematology. 2006 Jun;11(3):139-46. doi: 10.1080/10245330600667583.
8
The relationship between ABO groups and subgroups, factor VIII and von Willebrand factor.
Haematologica. 2007 Feb;92(2):236-9. doi: 10.3324/haematol.10457.
9
A systematic review of randomized controlled trials for plasma exchange in the treatment of thrombotic thrombocytopenic purpura.
Transfus Med. 2007 Feb;17(1):17-35. doi: 10.1111/j.1365-3148.2006.00720.x.
10
Comparison and stability of ADAMTS13 activity in therapeutic plasma products.
Transfusion. 2007 Jan;47(1):120-5. doi: 10.1111/j.1537-2995.2007.01074.x.
Zotero 插件